04/08/2026
As emerging drug trends continue to impact the communities we serve, staying informed is more important than ever.
Pennsylvania Department of Drug and Alcohol Programs recently highlighted growing concerns around Medetomidine in the drug supply and its potential risks.
We encourage providers, clinicians, and community partners to take advantage of this upcoming webinar featuring Michael Lynch from UPMC Health Plan, who will discuss clinical considerations for both outpatient and residential care.
If you’re looking to stay ahead of emerging substances and better support the individuals we serve, this is a valuable opportunity to learn more.
👉 Check out the registration details shared by DDAP and join the conversation.